Exactech, Inc. (MM) (NASDAQ:EXAC)
Historical Stock Chart
5 Years : From Jun 2011 to Jun 2016
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and
joint restoration products for hip, knee, shoulder, spine and biologic
materials, will release its first quarter 2012 financial results on
Tuesday, May 1, 2012. A copy of the earnings release will be available
The company will hold a conference call with CEO Dr. William
Petty and key members of the management team on Wednesday, May 2 at
10:00 a.m. Eastern Time. The call will cover Exactech’s first
quarter 2012 results. Dr. Petty will open the conference call and a
question-and-answer session will follow.
To participate in the call, dial 1-877-941-1428 any time after
9:50 a.m. Eastern on May 2. International and local callers should dial 1-480-629-9665.
A live webcast of the call will be available at http://www.hawkassociates.com/profile/exac.cfm
This call will be archived for approximately 90 days.
Based in Gainesville, Fla., Exactech develops and markets orthopaedic
implant devices, related surgical instruments and biologic materials and
services to hospitals and physicians. The company manufactures many of
its orthopaedic devices at its Gainesville facility. Exactech’s
orthopaedic products are used in the restoration of bones and joints
that have deteriorated as a result of injury or diseases such as
arthritis. Exactech markets its products in the United States, in
addition to more than 30 markets in Europe, Latin America, Asia and the
Pacific. Additional information about Exactech, Inc. can be found at http://www.exac.com.
Copies of Exactech’s press releases, SEC filings, current price quotes
and other valuable information for investors may be found at http://www.exac.com
An investment profile on Exactech may be found at http://www.hawkassociates.com/profile/exac.cfm.
To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section 21E of
the Securities Exchange Act of 1934, which represent the company’s
expectations or beliefs concerning future events of the company’s
financial performance. These forward-looking statements are further
qualified by important factors that could cause actual results to differ
materially from those in the forward-looking statements. These factors
include the effect of competitive pricing, the company’s dependence on
the ability of third party manufacturers to produce components on a
basis which is cost-effective to the company, market acceptance of the
company’s products and the effects of government regulation. Results
actually achieved may differ materially from expected results included
in these statements.